JP2014176384A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014176384A5 JP2014176384A5 JP2014080591A JP2014080591A JP2014176384A5 JP 2014176384 A5 JP2014176384 A5 JP 2014176384A5 JP 2014080591 A JP2014080591 A JP 2014080591A JP 2014080591 A JP2014080591 A JP 2014080591A JP 2014176384 A5 JP2014176384 A5 JP 2014176384A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- och
- compound
- treatment
- following formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 27
- 206010028980 Neoplasm Diseases 0.000 claims 2
- 201000004624 Dermatitis Diseases 0.000 claims 1
- 206010016654 Fibrosis Diseases 0.000 claims 1
- 206010017533 Fungal infection Diseases 0.000 claims 1
- 206010020751 Hypersensitivity Diseases 0.000 claims 1
- 206010062016 Immunosuppression Diseases 0.000 claims 1
- 208000031888 Mycoses Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 230000001772 anti-angiogenic effect Effects 0.000 claims 1
- 230000003510 anti-fibrotic effect Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 208000010668 atopic eczema Diseases 0.000 claims 1
- 230000001363 autoimmune Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 230000004761 fibrosis Effects 0.000 claims 1
- 230000003463 hyperproliferative effect Effects 0.000 claims 1
- 230000001506 immunosuppresive effect Effects 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 238000012423 maintenance Methods 0.000 claims 1
- 230000007246 mechanism Effects 0.000 claims 1
- 210000005036 nerve Anatomy 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002062 proliferating effect Effects 0.000 claims 1
- 230000008929 regeneration Effects 0.000 claims 1
- 238000011069 regeneration method Methods 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 0 C[C@](C[C@](CC1)C[C@@](*)[C@@]1O)[C@](CC([C@](C)C=C(C)[C@]([C@@](*)C([C@](C)C[C@](C)C=CC=CC=C(C)[C@@](C[C@](CC[C@]1C)O[C@]1(C(C(N1[C@]2CCCC1)O)=O)O)O*)=O)O)=O)OC2=O Chemical compound C[C@](C[C@](CC1)C[C@@](*)[C@@]1O)[C@](CC([C@](C)C=C(C)[C@]([C@@](*)C([C@](C)C[C@](C)C=CC=CC=C(C)[C@@](C[C@](CC[C@]1C)O[C@]1(C(C(N1[C@]2CCCC1)O)=O)O)O*)=O)O)=O)OC2=O 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0216509.0 | 2002-07-16 | ||
| GB0216509A GB0216509D0 (en) | 2002-07-16 | 2002-07-16 | Production of polyketides and other natural products |
| GB0224922.5 | 2002-10-25 | ||
| GB0224922A GB0224922D0 (en) | 2002-10-25 | 2002-10-25 | Production of polyketides and other natural products |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009255660A Division JP2010075187A (ja) | 2002-07-16 | 2009-11-09 | ポリケチド、及び他の天然物の製造 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014176384A JP2014176384A (ja) | 2014-09-25 |
| JP2014176384A5 true JP2014176384A5 (enExample) | 2015-03-05 |
Family
ID=30117119
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004520912A Pending JP2005532809A (ja) | 2002-07-16 | 2003-07-16 | ポリケチド、及び他の天然物の製造 |
| JP2008028177A Expired - Fee Related JP4751899B2 (ja) | 2002-07-16 | 2008-02-07 | ポリケチド、及び他の天然物の製造 |
| JP2008028178A Ceased JP2008200039A (ja) | 2002-07-16 | 2008-02-07 | ポリケチド、及び他の天然物の製造 |
| JP2009255660A Withdrawn JP2010075187A (ja) | 2002-07-16 | 2009-11-09 | ポリケチド、及び他の天然物の製造 |
| JP2014080591A Pending JP2014176384A (ja) | 2002-07-16 | 2014-04-09 | ポリケチド、及び他の天然物の製造 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004520912A Pending JP2005532809A (ja) | 2002-07-16 | 2003-07-16 | ポリケチド、及び他の天然物の製造 |
| JP2008028177A Expired - Fee Related JP4751899B2 (ja) | 2002-07-16 | 2008-02-07 | ポリケチド、及び他の天然物の製造 |
| JP2008028178A Ceased JP2008200039A (ja) | 2002-07-16 | 2008-02-07 | ポリケチド、及び他の天然物の製造 |
| JP2009255660A Withdrawn JP2010075187A (ja) | 2002-07-16 | 2009-11-09 | ポリケチド、及び他の天然物の製造 |
Country Status (15)
| Country | Link |
|---|---|
| US (7) | US7300942B2 (enExample) |
| EP (5) | EP2277898A3 (enExample) |
| JP (5) | JP2005532809A (enExample) |
| CN (1) | CN100569944C (enExample) |
| AT (1) | ATE370161T1 (enExample) |
| AU (1) | AU2003246965B2 (enExample) |
| BR (1) | BR0312691A (enExample) |
| CA (1) | CA2492153C (enExample) |
| CY (1) | CY1107764T1 (enExample) |
| DE (1) | DE60315723T2 (enExample) |
| DK (1) | DK1589031T3 (enExample) |
| ES (2) | ES2544624T3 (enExample) |
| MX (1) | MXPA05000139A (enExample) |
| PT (1) | PT1589031E (enExample) |
| WO (1) | WO2004007709A2 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1589031T3 (da) | 2002-07-16 | 2007-12-10 | Biotica Tech Ltd | Fremstillingaf polyketider og andre naturlige produkter |
| CN102144961A (zh) | 2003-09-18 | 2011-08-10 | 参天制药株式会社 | 经巩膜递送 |
| EP1740710A1 (en) * | 2004-04-27 | 2007-01-10 | Wyeth | Labeling of rapamycin using rapamycin-specific methylases |
| BRPI0511777A (pt) * | 2004-06-03 | 2008-01-15 | Wyeth Corp | complexo de meridamicina sintase, célula hospedeira, policetìdeo sintase sintética, seqüência de ácido nucleico, vetor recombinante, ácido nucleico isolado, construção de ácido nucleico quimérico, métodos para produzir um composto de policetìdeo e para determinar o requerimento estrutural da atividade de policetìdio, análogo de meridamicina, cepa de streptomyces mutante, ceto meridamicina c36 ou um sal farmaceuticamente aceitável da mesma, composto de desoximeridamicina, sais ou misturas farmaceuticamente aceitável do mesmo, composição farmacêutica, uso de um composto, cepa de actinomiceto m507, e, métodos para produzir um macrolìdeo e para produzir um composto |
| GB0417852D0 (en) * | 2004-08-11 | 2004-09-15 | Biotica Tech Ltd | Production of polyketides and other natural products |
| EP1828203A2 (en) | 2004-12-20 | 2007-09-05 | Wyeth | Rapamycin derivatives and the uses thereof in the treatment of neurological disorders |
| EP1828202B1 (en) | 2004-12-20 | 2012-03-14 | Wyeth LLC | Rapamcyin analogues and the uses thereof in the treatment of neurological, proliferative and inflammatory disorders |
| EP1853259A1 (en) | 2005-02-09 | 2007-11-14 | Macusight, Inc. | Formulations for ocular treatment |
| US8663639B2 (en) | 2005-02-09 | 2014-03-04 | Santen Pharmaceutical Co., Ltd. | Formulations for treating ocular diseases and conditions |
| GB0504994D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Novel compounds |
| EP1896018A2 (en) * | 2005-03-11 | 2008-03-12 | Biotica Technology Limited | Medical uses of 39-desmethoxyrapamycin and analogues thereof |
| BRPI0608726A2 (pt) * | 2005-03-11 | 2011-03-15 | Biotica Tech Ltd | uso de um análogo de 39-desmetoxirapamicina ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica |
| GB0504995D0 (en) | 2005-03-11 | 2005-04-20 | Biotica Tech Ltd | Use of a compound |
| EP2001438A2 (en) | 2006-02-09 | 2008-12-17 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| EP2001466B1 (en) | 2006-03-23 | 2016-01-06 | Santen Pharmaceutical Co., Ltd | Low-dose rapamycin for the treatment of vascular permeability-related diseases |
| GB0609962D0 (en) * | 2006-05-19 | 2006-06-28 | Biotica Tech Ltd | Novel compounds |
| GB0609963D0 (en) * | 2006-05-19 | 2006-06-28 | Biotica Tech Ltd | Novel compounds |
| KR100750810B1 (ko) | 2006-08-07 | 2007-08-22 | 동국제약 주식회사 | 스트렙토마이세스 히그로스코피쿠스 ａｔｃｃ １４８９１변이주 및 이를 이용한 타크로리무스 생산 방법 |
| ES2615629T3 (es) * | 2007-04-02 | 2017-06-07 | Newsouth Innovations Pty Limited | Métodos para producir metabolitos secundarios |
| TW200845960A (en) * | 2007-04-05 | 2008-12-01 | Wyeth Corp | Wortmannin-rapalog conjugate and uses thereof |
| US20080287675A1 (en) * | 2007-05-18 | 2008-11-20 | Abbott Laboratories | Cascade system |
| CA2711765A1 (en) * | 2008-01-11 | 2009-07-16 | Massachusetts Eye & Ear Infirmary | Conditional-stop dimerizable caspase transgenic animals |
| CN102224242B (zh) | 2008-09-24 | 2014-09-24 | 中国科学院上海有机化学研究所 | 新基因簇 |
| GB0904540D0 (en) | 2009-03-17 | 2009-04-29 | Biotica Tech Ltd | Novel compounds and methods for their production |
| GB0914589D0 (en) | 2009-08-20 | 2009-09-30 | Biotica Tech Ltd | Novel compounds and methods for their production |
| GB0917817D0 (en) | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
| GB0917816D0 (en) | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
| CA2820800A1 (en) | 2010-12-08 | 2012-06-14 | Oslo University Hospital Hf | Triazole derivatives as wnt signaling pathway inhibitors |
| EP2589383A1 (en) | 2011-11-06 | 2013-05-08 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Berlin | FKBP subtype-specific rapamycin analogue for use in treatment of diseases |
| GB201122305D0 (en) * | 2011-12-23 | 2012-02-01 | Biotica Tech Ltd | Novel compound |
| US20150073043A1 (en) * | 2012-01-19 | 2015-03-12 | Institut Pasteur Of Shanghai, Chinese Academy Of Sciences | Use of phosphorylation pathway-related factor in regulating function of regulatory t cell |
| KR101331491B1 (ko) | 2012-03-21 | 2013-11-20 | 이화여자대학교 산학협력단 | 증가된 라파마이신 생성능을 갖는 신규 미생물 균주 |
| GB201312318D0 (en) | 2013-07-09 | 2013-08-21 | Isomerase Therapeutics Ltd | Novel methods and compounds |
| EP3341381A4 (en) * | 2015-08-28 | 2019-06-12 | Buck Institute for Research on Aging | RAPAMYCIN ANALOGUE WITH IMPROVED MTORC1 SPECIFICITY |
| AU2018219317A1 (en) | 2017-02-10 | 2019-09-26 | Mount Tam Therapeutics, Inc. | Rapamycin analog |
| WO2019157363A2 (en) * | 2018-02-09 | 2019-08-15 | Mount Tam Therapeutics, Inc. | Rapamycin analog for prevention and/or treatment of cancer |
| US20210030726A1 (en) * | 2018-02-09 | 2021-02-04 | Torcept Therapeutics, Inc. | Rapamycin analog for prevention and/or treatment of neurodegnerative conditions |
| CN113766916B (zh) | 2019-01-22 | 2024-04-05 | 艾奥维安制药公司 | Mtorc调节剂及其用途 |
| CN115125179B (zh) * | 2021-03-26 | 2023-10-27 | 上海医药工业研究院 | 产雷帕霉素的基因工程菌及其应用 |
| WO2022272154A2 (en) * | 2021-06-25 | 2022-12-29 | Apertor Pharmaceuticals, Inc. | Small molecule compounds |
| US20230104503A1 (en) * | 2021-06-25 | 2023-04-06 | The Regents Of The University Of California | Small molecule compounds |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA737247B (en) | 1972-09-29 | 1975-04-30 | Ayerst Mckenna & Harrison | Rapamycin and process of preparation |
| US3993749A (en) | 1974-04-12 | 1976-11-23 | Ayerst Mckenna And Harrison Ltd. | Rapamycin and process of preparation |
| SE416705B (sv) | 1978-02-27 | 1981-02-02 | Torsten & Andersson Kaj | Anordning for utskjutning av bollar |
| GB2165090A (en) | 1984-09-26 | 1986-04-03 | Philips Electronic Associated | Improving the field distribution in high voltage semiconductor devices |
| JPS6453991A (en) | 1987-08-25 | 1989-03-01 | Mitsubishi Electric Corp | Magazine-cum-reel |
| US5109112A (en) | 1989-01-19 | 1992-04-28 | Merck & Co., Inc. | FK-506 cytosolic binding protein |
| US5023262A (en) | 1990-08-14 | 1991-06-11 | American Home Products Corporation | Hydrogenated rapamycin derivatives |
| US5221670A (en) | 1990-09-19 | 1993-06-22 | American Home Products Corporation | Rapamycin esters |
| US5143918A (en) * | 1990-10-11 | 1992-09-01 | Merck & Co., Inc. | Halomacrolides and derivatives having immunosuppressive activity |
| WO1993013663A1 (en) | 1992-01-17 | 1993-07-22 | Abbott Laboratories | Method of directing biosynthesis of specific polyketides |
| US5093338A (en) | 1991-04-23 | 1992-03-03 | Merck & Co., Inc. | Lipophilic macrolide useful as an immunosuppressant |
| US5091389A (en) | 1991-04-23 | 1992-02-25 | Merck & Co., Inc. | Lipophilic macrolide useful as an immunosuppressant |
| US5138051A (en) | 1991-08-07 | 1992-08-11 | American Home Products Corporation | Rapamycin analogs as immunosuppressants and antifungals |
| EP0586512A1 (en) | 1991-05-31 | 1994-03-16 | Pfizer Inc. | Use of rapamycin prodrugs as immunosuppressant agents |
| US5763590A (en) | 1991-10-11 | 1998-06-09 | Vertex Pharmaceuticals, Inc. | Isolation of an Mr 52,000 FK506 binding protein and molecular cloning of a corresponding human cDNA |
| GB9125660D0 (en) | 1991-12-03 | 1992-01-29 | Smithkline Beecham Plc | Novel compound |
| US5498597A (en) | 1992-01-17 | 1996-03-12 | Dana-Farber Cancer Institute, Inc. | FKBP-13, an FK506-binding immunophilin |
| JP3140228B2 (ja) * | 1992-02-17 | 2001-03-05 | ファイザー製薬株式会社 | 新規な大環状ラクトンおよびその生産菌 |
| ZA935112B (en) | 1992-07-17 | 1994-02-08 | Smithkline Beecham Corp | Rapamycin derivatives |
| GB9221220D0 (en) | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
| GB9302569D0 (en) * | 1993-02-10 | 1993-03-24 | Smithkline Beecham Plc | Novel compound |
| US5354845A (en) | 1993-04-21 | 1994-10-11 | Children's Research Institute | FK-506 and rapamycin specific binding immunophilin |
| GB9315914D0 (en) * | 1993-07-31 | 1993-09-15 | Smithkline Beecham Plc | Novel compound |
| US5387680A (en) * | 1993-08-10 | 1995-02-07 | American Home Products Corporation | C-22 ring stabilized rapamycin derivatives |
| US5373014A (en) | 1993-10-08 | 1994-12-13 | American Home Products Corporation | Rapamycin oximes |
| US5378836A (en) | 1993-10-08 | 1995-01-03 | American Home Products Corporation | Rapamycin oximes and hydrazones |
| US5391730A (en) | 1993-10-08 | 1995-02-21 | American Home Products Corporation | Phosphorylcarbamates of rapamycin and oxime derivatives thereof |
| UA41884C2 (uk) * | 1993-11-05 | 2001-10-15 | Амерікан Хоум Продактс Корпорейшн | Спосіб відокремлення рапаміцину від кислотних, основних та неполярних нейтральних домішок, присутніх в концентраті екстрактів ферментаційного бульйону або маточних розчинів |
| WO1995014023A1 (en) * | 1993-11-19 | 1995-05-26 | Abbott Laboratories | Semisynthetic analogs of rapamycin (macrolides) being immunomodulators |
| ATE191218T1 (de) | 1993-12-17 | 2000-04-15 | Novartis Ag | Rapamycin-derivate als immunosuppressoren |
| US5457182A (en) | 1994-02-15 | 1995-10-10 | Merck & Co., Inc. | FK-506 cytosolic binding protein, FKBP12.6 |
| US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| US5563145A (en) | 1994-12-07 | 1996-10-08 | American Home Products Corporation | Rapamycin 42-oximes and hydroxylamines |
| PL184731B1 (pl) | 1995-06-09 | 2002-12-31 | Novartis Ag | Pochodne rapamycyny, zastosowanie pochodnych rapamycyny i kompozycja farmaceutyczna |
| ATE286133T1 (de) | 1995-07-06 | 2005-01-15 | Univ Leland Stanford Junior | Zellfreie synthese von polyketiden |
| US5780462A (en) | 1995-12-27 | 1998-07-14 | American Home Products Corporation | Water soluble rapamycin esters |
| GB9710962D0 (en) | 1997-05-28 | 1997-07-23 | Univ Cambridge Tech | Polyketides and their synthesis |
| JP4173551B2 (ja) | 1996-07-05 | 2008-10-29 | バイオティカ テクノロジー リミティド | 新規エリスロマイシン及びその製造方法 |
| EP0956034B1 (en) | 1996-07-30 | 2002-08-21 | Novartis AG | Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin |
| AU4246197A (en) * | 1996-09-09 | 1998-03-26 | American Home Products Corporation | Rapamycin derivatives with unnatural stereochemistries |
| CA2286311A1 (en) * | 1997-04-09 | 1998-10-15 | Isotechnika, Inc. | Method for production of antibodies to specific sites of rapamycin |
| US6015815A (en) | 1997-09-26 | 2000-01-18 | Abbott Laboratories | Tetrazole-containing rapamycin analogs with shortened half-lives |
| AU4549999A (en) * | 1998-06-08 | 1999-12-30 | Advanced Medicine, Inc. | Novel polyene macrolide compounds and uses |
| GB9814006D0 (en) | 1998-06-29 | 1998-08-26 | Biotica Tech Ltd | Polyketides and their synthesis |
| GB9814622D0 (en) | 1998-07-06 | 1998-09-02 | Biotica Tech Ltd | Polyketides,their preparation,and materials for use therein |
| US6150513A (en) | 1998-09-16 | 2000-11-21 | Kosan Biosciences, Inc. | Polyketide synthase enzymes and recombinant DNA constructs therefor |
| ATE346938T1 (de) * | 1998-10-02 | 2006-12-15 | Kosan Biosciences Inc | Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen |
| SE516023C2 (sv) | 1999-06-24 | 2001-11-12 | Abb Ab | Industrirobot innefattande en växellådskonfiguration samt förfarande i en industrirobot |
| AU777997B2 (en) | 1999-07-09 | 2004-11-11 | Oregon Health And Science University | Compositions and methods for promoting nerve regeneration |
| US6569867B2 (en) | 1999-10-01 | 2003-05-27 | Kosan Biosciences, Inc. | Polyketide derivatives |
| ATE356880T1 (de) * | 1999-10-29 | 2007-04-15 | Kosan Biosciences Inc | Rapamycin analoge |
| WO2001079520A1 (en) | 2000-04-13 | 2001-10-25 | Biotica Technology Limited | Hybrid glycosylated products and their production and use |
| JP2004515459A (ja) * | 2000-05-17 | 2004-05-27 | コーサン バイオサイエンシーズ， インコーポレイテッド | ポリケチド誘導体 |
| GB0019986D0 (en) | 2000-08-14 | 2000-10-04 | Biotica Tech Ltd | Polyketides and their synthesis |
| US6534693B2 (en) * | 2000-11-06 | 2003-03-18 | Afmedica, Inc. | Surgically implanted devices having reduced scar tissue formation |
| GB0128680D0 (en) | 2001-11-29 | 2002-01-23 | Biotica Tech Ltd | Hybrid glycosylated products and their production and use |
| CN100522967C (zh) * | 2002-02-01 | 2009-08-05 | 阿里亚德基因治疗公司 | 含磷化合物及其应用 |
| AU2007237187B2 (en) | 2002-07-16 | 2010-08-05 | Biotica Technology Limited | Production of polyketides |
| DK1589031T3 (da) | 2002-07-16 | 2007-12-10 | Biotica Tech Ltd | Fremstillingaf polyketider og andre naturlige produkter |
| GB0216509D0 (en) | 2002-07-16 | 2002-08-28 | Biotica Tech Ltd | Production of polyketides and other natural products |
| CA2621093A1 (en) | 2002-07-16 | 2004-01-22 | Biotica Technology Limited | Production of polyketides and other natural products |
-
2003
- 2003-07-16 DK DK05075774T patent/DK1589031T3/da active
- 2003-07-16 EP EP10179385A patent/EP2277898A3/en not_active Withdrawn
- 2003-07-16 EP EP05077470A patent/EP1655372A3/en not_active Withdrawn
- 2003-07-16 ES ES03764029.9T patent/ES2544624T3/es not_active Expired - Lifetime
- 2003-07-16 CA CA2492153A patent/CA2492153C/en not_active Expired - Fee Related
- 2003-07-16 EP EP05075774A patent/EP1589031B1/en not_active Expired - Lifetime
- 2003-07-16 DE DE60315723T patent/DE60315723T2/de not_active Expired - Lifetime
- 2003-07-16 WO PCT/GB2003/003230 patent/WO2004007709A2/en not_active Ceased
- 2003-07-16 EP EP03764029.9A patent/EP1521828B1/en not_active Expired - Lifetime
- 2003-07-16 EP EP08075113A patent/EP1967520A2/en not_active Withdrawn
- 2003-07-16 BR BR0312691-9A patent/BR0312691A/pt not_active IP Right Cessation
- 2003-07-16 CN CNB038169169A patent/CN100569944C/zh not_active Expired - Fee Related
- 2003-07-16 PT PT05075774T patent/PT1589031E/pt unknown
- 2003-07-16 JP JP2004520912A patent/JP2005532809A/ja active Pending
- 2003-07-16 ES ES05075774T patent/ES2296063T3/es not_active Expired - Lifetime
- 2003-07-16 MX MXPA05000139A patent/MXPA05000139A/es active IP Right Grant
- 2003-07-16 US US10/497,135 patent/US7300942B2/en not_active Expired - Lifetime
- 2003-07-16 AU AU2003246965A patent/AU2003246965B2/en not_active Ceased
- 2003-07-16 AT AT05075774T patent/ATE370161T1/de active
-
2005
- 2005-11-08 US US11/269,215 patent/US20060078980A1/en not_active Abandoned
-
2007
- 2007-07-16 US US11/778,319 patent/US7645768B2/en not_active Expired - Fee Related
- 2007-07-16 US US11/778,264 patent/US7390895B2/en not_active Expired - Lifetime
- 2007-10-15 CY CY20071101328T patent/CY1107764T1/el unknown
- 2007-10-31 US US11/931,474 patent/US20080287482A1/en not_active Abandoned
-
2008
- 2008-02-07 JP JP2008028177A patent/JP4751899B2/ja not_active Expired - Fee Related
- 2008-02-07 JP JP2008028178A patent/JP2008200039A/ja not_active Ceased
-
2009
- 2009-11-09 JP JP2009255660A patent/JP2010075187A/ja not_active Withdrawn
-
2011
- 2011-03-11 US US13/046,304 patent/US9040259B2/en not_active Expired - Lifetime
-
2014
- 2014-04-09 JP JP2014080591A patent/JP2014176384A/ja active Pending
-
2015
- 2015-03-02 US US14/635,979 patent/US9605001B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014176384A5 (enExample) | ||
| JP2016501221A5 (enExample) | ||
| CY1120474T1 (el) | Χημικες ενωσεις | |
| JP2016514159A5 (enExample) | ||
| JP2017509667A5 (enExample) | ||
| PH12017500276A1 (en) | Aminopyrimidinyl compounds as jak inhibitors | |
| EA201691940A1 (ru) | Новые соединения | |
| MX2017007748A (es) | Compuestos de heteroarilo anulares fusionados y su uso como inhibidores del receptor de la tirocina cinasa (trk). | |
| MX2016010266A (es) | Formas solidas cristalinas de n-{4-[(6,7-dimetoxiquinolin-4-il)oxi ]fenil}-n'-(4-fluorofenil)ciclopropan-1,1-dicarboxamida, procesos para elaboracion y metodos de uso. | |
| EA201891553A1 (ru) | Ингибиторы syk | |
| EP4321513A3 (en) | Pyrrolotriazine compounds as tam inhibitors | |
| CY1119231T1 (el) | Θειαδιαζολιδινοδιονες ως αναστολεις της gsk-3 | |
| WO2015200481A8 (en) | Mnk inhibitors and methods related thereto | |
| EA201592068A1 (ru) | Ингибиторы энхансера zeste гомолога 2 | |
| JP2016518337A5 (enExample) | ||
| JP2014507446A5 (enExample) | ||
| EP4275756A3 (en) | Bipyrazole derivatives as jak inhibitors | |
| JP2017514910A5 (enExample) | ||
| JP2014235432A5 (enExample) | ||
| JP2018521020A5 (enExample) | ||
| MX392353B (es) | Procedimientos para preparar compuestos de tipo oxatiazina | |
| MX392710B (es) | Silicato de zirconio microporoso para el tratamiento de la hiperpotasemia. | |
| JP2016540015A5 (enExample) | ||
| EP2776042A4 (en) | ACTIVE COMBINATION THERAPY FOR THE TREATMENT OF SOLID TUMORS | |
| EP4599830A3 (en) | Isoxazoline compounds for use in treating demodicosis |